Islet Transplantation in People with Unstable or “Brittle” Type 1 Diabetes

About the study

Islet transplants are intended to help control blood glucose without insulin injections in advanced type I diabetes by replacing destroyed islets with new ones. No surgery is needed. The islet cells from a deceased donor’s pancreas are taken and injected into a major blood vessel in the subject’s body. The islet cells then begin making insulin.

Islet transplant is experimental and Dr. Witkowski, the Principal Investigator at The University of Chicago Medicine is conducting clinical trials to evaluate the long-term benefits and risks of the procedure.

Eligibility Criteria

Participants must meet the following requirements:

  •  Must be between the ages of 18 and 65
  •  Must have type 1 diabetes for at least last 5 years
  •  Must be on insulin injections or on pump
  •  Must be available for clinic visits for the duration of the study
  •  Must meet study criteria as evaluated by the Principal Investigator: Dr. Witkowski

How to participate

For more information on this research study please contact Islet Cell Coordinator: Lindsay Schenck, RN, BSN at 773-702-2504 or visit our website at: